Gujarat Kidney and Super Speciality
add_icon

Gujarat Kidney and Super Speciality

101.79
-4.42
(-4.16%)
Market Cap
802.55 Cr
PE Ratio
62.72
Volume
1,16,999.00
Day High - Low
105.94 - 100.51
52W High-Low
123.00 - 98.36
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
802.55 Cr
EPS
1.85
PE Ratio
62.72
PB Ratio
2.94
Book Value
36.06
EBITDA
16.70
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
35.02
Debt to Equity
0.39
Forecast For
Actual

Company News

View All News
Caret
positive
Gujarat Kidney and Super Speciality Limited completed acquisition of Parekhs Hospital Private Limited as wholly owned subsidiary for ₹77 crore cash consideration on March 22, 2026.
negative
Gujarat Kidney and Super Speciality Limited paid ₹3,30,400 each to NSE and BSE on March 20, 2026, for non-compliance with quarterly financial results submission under Regulation 33.
neutral
Gujarat Kidney And Superspeciality Limited board appointed secretarial and internal auditors for FY 2025-26, approved postal ballot notice, and ratified February 2026 financial results meeting.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,145.00
#1 1,02,734.14
56.74
#1 21,994.30
14.76
#1 1,505
36.08
33.69
956.90
93,084.30
66.17
7,184.10
#1 28.65
1,076
26.01
31.20
799.20
60,336.26
63.24
7,849.70
13.25
809
-22.38
33.26
1,624.60
33,200.46
43.35
5,575.00
12.29
790
-34.33
32.92
621.30
32,190.86
90.51
4,286.70
15.12
337
-8.85
43.82
969.60
26,061.92
52.56
3,771.40
12.59
481
-33.52
23.74
630.50
25,228.76
82.22
3,067.00
21.98
415
-43.89
38.88
420.20
13,298.07
83.68
1,757.00
27.65
110
#1 54.61
35.32
5,155.50
11,533.32
#1 24.44
599.90
11.69
58
12.46
43.87
1,106.00
11,232.44
43.65
1,566.90
17.46
244
7.26
34.09
Growth Rate
Revenue Growth
634.55 %
Net Income Growth
458.82 %
Cash Flow Change
1,024.79 %
ROE
120.81 %
ROCE
177.89 %
EBITDA Margin (Avg.)
-14.69 %

Quarterly Financial Results

Quarterly Financials
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
9
12
10
15
13
23
Expenses
5
7
7
7
8
16
EBITDA
5
5
3
9
5
7
Operating Profit %
52 %
39 %
27 %
57 %
40 %
30 %
Depreciation
1
1
1
1
1
1
Interest
0
0
0
0
0
1
Profit Before Tax
4
4
2
8
4
5
Tax
1
1
0
2
1
1
Net Profit
3
3
1
5
3
4
EPS in ₹
0.65
0.52
0.22
0.85
0.47
0.52

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
4
4
21
55
Fixed Assets
3
0
14
31
Current Assets
1
1
7
22
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
1
4
7
24
Total Equity & Liabilities
4
4
21
55
Current Liabilities
4
4
4
22
Non Current Liabilities
0
0
6
7
Total Equity
0
0
11
27
Reserve & Surplus
0
0
2
15
Share Capital
0
0
0
11

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
1
2
Investing Activities
0
0
-18
Operating Activities
0
1
14
Financing Activities
0
-1
6

Share Holding

% Holding
Mar 2025
Dec 2025
Promoter
99.10 %
71.45 %
FIIs
0.00 %
10.47 %
DIIs
0.00 %
1.67 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
11.57 %
Others
0.90 %
4.84 %
No of Share Holders
7
7

Announcements

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Wholly Own Subsidiary.7 hrs ago
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015-Update.2 days ago
Announcement under Regulation 30 (LODR)-Change in Management4 days ago
Announcement under Regulation 30 (LODR)-Change in Management4 days ago
Board Meeting Outcome for Outcome For Board Meeting Outcome For Board Meeting Hold On 19Th March 2026.4 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Intimation For Receipt Of Notice For Non-Compliance With Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 205 days ago
Results-Delay in Financial Results10 days ago
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 15, 2026
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025Feb 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 14, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 14 2026 For The Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025 And Other Businesses MFeb 14, 2026
Board Meeting Intimation for Postponement And Rescheduling Of Board MeetingFeb 11, 2026
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 10, 2026
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.Feb 05, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.Jan 06, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026Jan 02, 2026
Closure of Trading WindowDec 30, 2025
Listing of Equity Shares of Gujarat Kidney and Super Speciality LtdDec 30, 2025

Technical Indicators

RSI(14)
Neutral
46.04
ATR(14)
Volatile
3.61
STOCH(9,6)
Neutral
30.07
STOCH RSI(14)
Neutral
21.01
MACD(12,26)
Bearish
-0.68
ADX(14)
Weak Trend
20.32
UO(9)
Bearish
49.22
ROC(12)
Downtrend And Accelerating
-2.51
WillR(14)
Neutral
-57.72